Intravitreal Anti-Vascular Endothelial Growth Factor Use in France During the Coronavirus Disease 2019 Pandemic.
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 33331873.
- Also identified by DOI 10.1001/jamaophthalmol.2020.5594 and PMC identifier 7747036.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
This cohort study uses data from the French National Health Data System to assess the decline in the use of intravitreal anti–vascular endothelial growth factors before, during, and after pandemic-associated lockdown periods.
Medical subject headings
- Angiogenesis Inhibitors
- COVID-19
- Drug Utilization
- SARS-CoV-2
- Vascular Endothelial Growth Factor A